Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone

British Journal of Ophthalmology

Volumn 88, Issue 11, 2004, Pages 1380-1386

  Ebner, Roberto ^a,b   Devoto, M H ^b   Weil, D ^c   Bordaberry, M ^d   Mir, C ^d   Martinez, H ^d   Bonelli, L ^c   Niepomniszcze, H ^b  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b Hospital de Clínicas ^*  (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DRUG SAFETY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; EYE MOVEMENT; FEMALE; FOLLOW UP; HUMAN; INFERIOR RECTUS MUSCLE; LEVATOR PALPEBRAE MUSCLE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUPERIOR RECTUS MUSCLE; THICKNESS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DIPLOPIA; EYE MOVEMENTS; FEMALE; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISION, BINOCULAR;

EID: 7044229404     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.046193     Document Type: Article

References (41)

1. Brain R. Cortisone in exophtalmos, report on a therapeutic trial of cortisone and corticotrophin (ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955;1:6-9.
2. Brown J, Coburn JW, Wigod RA, et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;34:786-95.
3. Werner SC. Predniosne in emergency treatment of malignant exophthalmos. Lancet 1966;1:1004-7.
4. Day MR, Carroll FD. Corticosteroids in the tratment of optic nerve involvement, associated with thyroid dysfunction. Arch Ophthalmol 1968;79:279-82.
5. Fiebel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974;78:800-5.
6. Apers RCL, Oosterhuis JA, Goslings BM, et al. Prednisone treatment in endocrine opthalmopathy. Mod Probl Ophthalmol 1975;14:414-20.
7. Sergott RC, Glaser JS. Graves' ophthalmopathy. A clinical and immunologic review. Surv Ophthalmol 1981;26:1-21.
8. Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984;5:200-20.
9. Leone Ch. The management of ophthalmic Graves' disease. Ophthalmology 1984;91:770-9.
10. McConahey WM. Medical therapy. In: Gorman CA, Waller RR, Dyer JA, eds. In: The eye and orbit in thyroid disease. New York: Raven Press, 1984:317-24.
11. Nagayama Y, Izumi M, Kiriyama T, et al. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisone pulse therapy. Acta Endocrinol 1987;116:513-18.
12. Kendall-Taylor P, Combie AL, Stephenson AM, et al. Intraveous methylprednisone in the tratment of Graves' opthalmopathy. BMJ 1988;297:1547-78.
13. Bartalena L, Marcocci C, Bogazzi F, et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321:1349-52.
14. Kazim M, Trokel S, Moore S. Treatment of acute Graves' orbitopathy. Ophthalmology 1991;98:1443-8.
15. Hiromatsu Y, Tanaka K, Sato M, et al. Intravenous methylprednisone pulse therapy for Graves' ophthalmopathy. Endocr J 1993;40:63-72.
16. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
17. Gebertt S. Depot-methylprednisolone for subconjuntival and retrobulbar injections. Lancet 1961;2:344-5.
18. Garber MI. Methylprednisolone in the treatment of exophthalmos. Lancet 1966;1:958-60.
19. Della Casa F. Zur Therapie des malignen Exophthlmus. Ophthalmologica 1970;161:145-51.
20. Cant JS. The assessment and treatment of endocrine exophthalmos. Proc Roy Soc Med 1970;63:783-6.
21. Ivy HK. Medical aproach to ophthalmopathy of Graves' disease. Mayo Clin Proc 1972;47:980-5.
22. Thomas ID, Hart JK. Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy. Med J Aust 1974;2:484-7.
23. Kramar P. Manegement of eye changes of Graves' disease. Surv Ophthalmol 1974;18:369-82.
24. Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale of management. Arch Ophthalmol 1978;96:1199-209.
25. Marcocci C, Bartalena L, Panicucci M, et al. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study. Clin Endocrinol 1987;27:33-42.
26. Huber A. Ocular motility in Graves' disease. Neuroophthalmology 1984;4:227-36.
27. Feibel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974;78:800-5.
28. Jordan DC, Flood JG, Lapostata M, et al. Normal reference laboratory values. N Eng J Med 1992;327:718-24.
29. Goodman AG, Gilman LS. Adrenocortical steroids and their synthetic analogs. In: The pharmacological basis of therapeutics, 9th ed. Chapter 59. New York: McGraw-Hill, 1996:1465-76.
30. Koorneef L. New insights in the human orbital connective tissue. Arch Ophthalmol 1977;95:1269-73.
31. Koorneef L. Orbital septa: anatomy and function. Ophthalmology 1979;86:876-80.
32. Waller SG, Taboada J, O'Connor P. Retrobulbar anesthesia risk. Ophthalmology 1993;100:506-10.
33. Wearne MJ, Flaxel ChJ, Gray P, et al. Vitreoretinal surgery after inadvertent globe penetration during local ocular anesthesia. Ophthalmology 1998;105:371-6.
34. Gomez-Ulla F, Gonzales F, y Ruiz-Fraga C, Unintentional intraocular injection of corticosteroids. Acta Ophthalmol 1993;71:419-21.
35. Bullock JD, Warwar RE, Green R. Ocular explosions from periocular anesthetic injections. Ophthalmology 1999;106:2341-53.
36. Lam DSC, Law RWK, Leung ATS, et al. Intraorbital needle fragment: a rare complication of retrobulbar injection. Arch Ophthalmol 1999;117:1089-90.
37. Egbert JE, Schwartz S, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 1996;121:638-42.
38. Teus MA, Teruel JL, Pascual J, et al. Corticosteroid-induced toxic optic neuropathy. Am J Ophthalmol 1991;112:605-6.
39. Droste PJ, Ellis FD, Sondhi N, et al. Linear subcutaneous fat atrophy after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol 1988;105:65-9.
40. Fraunfelder FT, Grove JA. In: Drug-induced ocular side effects, 4th ed. Baltimore: Willams & Wilkins, 1996:323-8.
41. Lee AG, Brazis PW. Thyroid eye disease, Graves' ophthalmopathy. In: Clinical pathways in neuro-ophtalmology. New York: Thieme Medical, 1998:270-1.